← FDA DRUG APPROVALS

FDA ANDA · ANDA075820

FLUTAMIDE

Sponsor: ACTAVIS LABS FL INC

APPLICATION
ANDA075820
TYPE
ANDA
ORIGINAL APPROVAL
2001-09-18
LATEST ACTION
2002-09-05
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

FLUTAMIDEDiscontinued
FLUTAMIDE 125MG · CAPSULE · ORAL

Approval history

2002-09-05Labeling · Supplement 1AP
2001-09-18OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →